CLYM   $6.98  -1.97% Market Closed After Close 6.98 0.0

Climb Bio, Inc.
Total Cash 223.14M
totalCashPerShare 3.327
EBITDA
Total Debt 100.00K
quickRatio 59.647
currentRatio 60.411
Total Revenue
debtToEquity 0.045
Revenue/Share
ROA -0.24544
ROE -0.38351002
grossProfits
freeCashflow -29.91M
operatingCashflow 57.00K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 33.13M
forwardPE
floatShares 26.24M
sharesOutstanding 67.06M
sharesShort 4.70M
sharesShortPriorMonth 1.13M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.78%
Short Ratio help_outline 4.69%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 3.328
Price To Book help_outline 1.15
earningsQuarterlyGrowth
netIncomeToCommon -64.19M
trailingEps -2.22%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount 80
lastUpdated Nov. 2, 2024, 10:17 a.m.